TIX 100
Alternative Names: TIX-100Latest Information Update: 31 Jan 2025
Price :
$50 *
At a glance
- Originator TIXiMED
- Class Antihyperglycaemics; Hepatoprotectants; Small molecules
- Mechanism of Action Protein-protein interaction inhibitors; Thioredoxin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 19 Dec 2024 TIXiMED plans a clinical trial for Type I diabetes mellitus in January 2025 (PO)
- 04 Dec 2024 TIXiMED has patent protection for TIX 100 with composition of matter and method of use (TIXiMED website, December 2024)
- 04 Dec 2024 TIXiMED plans a clinical trial for TIX 100 in USA (TIXiMED website, December 2024)